1. Home
  2. VIRX vs AEHL Comparison

VIRX vs AEHL Comparison

Compare VIRX & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIRX
  • AEHL
  • Stock Information
  • Founded
  • VIRX 2007
  • AEHL 1993
  • Country
  • VIRX United States
  • AEHL United States
  • Employees
  • VIRX N/A
  • AEHL N/A
  • Industry
  • VIRX Biotechnology: Pharmaceutical Preparations
  • AEHL Building Materials
  • Sector
  • VIRX Health Care
  • AEHL Industrials
  • Exchange
  • VIRX Nasdaq
  • AEHL Nasdaq
  • Market Cap
  • VIRX 7.0M
  • AEHL 7.9M
  • IPO Year
  • VIRX N/A
  • AEHL 2007
  • Fundamental
  • Price
  • VIRX $0.19
  • AEHL $0.18
  • Analyst Decision
  • VIRX Buy
  • AEHL
  • Analyst Count
  • VIRX 4
  • AEHL 0
  • Target Price
  • VIRX $5.00
  • AEHL N/A
  • AVG Volume (30 Days)
  • VIRX 2.3M
  • AEHL 3.4M
  • Earning Date
  • VIRX 11-13-2024
  • AEHL 09-30-2024
  • Dividend Yield
  • VIRX N/A
  • AEHL N/A
  • EPS Growth
  • VIRX N/A
  • AEHL N/A
  • EPS
  • VIRX N/A
  • AEHL N/A
  • Revenue
  • VIRX N/A
  • AEHL $69,082,235.00
  • Revenue This Year
  • VIRX N/A
  • AEHL N/A
  • Revenue Next Year
  • VIRX N/A
  • AEHL N/A
  • P/E Ratio
  • VIRX N/A
  • AEHL N/A
  • Revenue Growth
  • VIRX N/A
  • AEHL 1.87
  • 52 Week Low
  • VIRX $0.13
  • AEHL $0.15
  • 52 Week High
  • VIRX $1.31
  • AEHL $6.41
  • Technical
  • Relative Strength Index (RSI)
  • VIRX 48.39
  • AEHL 38.53
  • Support Level
  • VIRX $0.20
  • AEHL $0.15
  • Resistance Level
  • VIRX $0.24
  • AEHL $0.29
  • Average True Range (ATR)
  • VIRX 0.03
  • AEHL 0.04
  • MACD
  • VIRX -0.00
  • AEHL 0.01
  • Stochastic Oscillator
  • VIRX 34.27
  • AEHL 23.93

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd is a manufacturer of ceramic tiles in China. Its ceramic tiles are used for exterior siding, interior flooring, and design in residential and commercial buildings. The company's products are Porcelain, Glazed, Glazed porcelain, Rustic, and polished glazed tiles. The Company operates in the manufacturing and sale of medium to high-end ceramic tiles and providing business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting.

Share on Social Networks: